MICHELLE BLACKSTON: Open Payments
NPI 1194277152 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,357 in 62 payments from 15 companies in 2025. Trend: 2023 $1,114 · 2024 $1,794 · 2025 $1,357
Food & beverage: $1,357
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 8 | $236 |
| Axsome Therapeutics, Inc. | 5 | $177 |
| Otsuka America Pharmaceutical, Inc. | 7 | $169 |
| ABBVIE INC. | 10 | $148 |
| Lundbeck LLC | 10 | $137 |
| Vanda Pharmaceuticals Inc. | 5 | $90 |
| Almatica Pharma LLC | 3 | $88 |
| E.R. Squibb & Sons, L.L.C. | 3 | $71 |
| Tris Pharma Inc | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
Products named: REXULTI, Auvelity, VRAYLAR, LYBALVI, HETLIOZ, LOREEV XR, COBENFY, Dyanavel XR.
Industry payments across MD — which companies pay providers there.
